ArticleProceedings of the National Academy of Sciences of the United States of America2024
Self-assembling dendrimer nanosystems for specific fluorine magnetic resonance imaging and effective theranostic treatment of tumors.
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Assembly delivery of bioactive matters: Advances, challenges, and prospects.Journal of advanced research · 2026Review
- Catalyzing MRI: An Enzymatic Strategy forChemical & biomedical imaging · 2026Article
- Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Multinuclear NMR and MRI Beyond Proton Imaging: Principles, Contrast Mechanisms, and Applications in Materials and Biomedicine.International journal of molecular sciences · 2026Review
- Nanobody conjugated with dendrimer nanoparticles effectively neutralizes tick-borne encephalitis virus.Scientific reports · 2025Article
- Nanomedicines for the treatment of genitourinary neoplasms.Materials today. Bio · 2025Review
- Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review).International journal of oncology · 2025Review
- Self-assembling dendrimer nanodrug formulations for decreased hERG-related toxicity and enhanced therapeutic efficacy.Science advances · 2025Article
- Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β-Catenin-HRP2 Signaling Axis.ACS applied materials & interfaces · 2025Article
- Targeting the phosphatidylglycerol lipid: An amphiphilic dendrimer as a promising antibacterial candidate.Science advances · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Zhenbin Lyu *Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.
Brigino Ralahy *Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.ORCID 0000-0002-6138-1092
Teodora-Adriana Perles-Barbacaru *Aix Marseille University, CNRS, Centre de Résonance Magnétique Biologique et Médicale, UMR 7339, Marseille 13385, France.
Ling Ding *Aix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.ORCID 0000-0001-5331-7827
Yifan JiangAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.ORCID 0000-0002-4084-9194
Baoping LianState Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, People's Republic of China.
Tom RousselAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.
Xi LiuAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.
Christina GalanakouAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.
Erik LauriniMolecular Biology and Nanotechnology Laboratory, Department of Engineering and Architecture, University of Trieste, Trieste 34127, Italy.ORCID 0000-0001-6092-6532
Aura TintaruAix Marseille University, CNRS, Institut de Chimie Radicalaire, UMR 7273, Marseille 13013, France.ORCID 0000-0001-8790-7753
Suzanne GiorgioAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.
Sabrina PriclMolecular Biology and Nanotechnology Laboratory, Department of Engineering and Architecture, University of Trieste, Trieste 34127, Italy.ORCID 0000-0001-8380-4474
Xiaoxuan LiuState Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, Center of Drug Discovery, Center of Advanced Pharmaceuticals and Biomaterials, China Pharmaceutical University, Nanjing 211198, People's Republic of China.
Monique BernardAix Marseille University, CNRS, Centre de Résonance Magnétique Biologique et Médicale, UMR 7339, Marseille 13385, France.
Juan IovannaCentre de Recherche en Cancérologie de Marseille, INSERM U1068, CNRS, UMR 7258, Institut Paoli-Calmettes, Aix Marseille Université, Marseille 13273, France.ORCID 0000-0003-1822-2237
Angèle ViolaAix Marseille University, CNRS, Centre de Résonance Magnétique Biologique et Médicale, UMR 7339, Marseille 13385, France.ORCID 0000-0002-6225-356X
Ling PengAix Marseille University, CNRS, Centre Interdisciplinaire de Nanoscience de Marseille (UMR 7325), Equipe Labellisée Ligue Contre le Cancer, Marseille 13288, France.ORCID 0000-0003-3990-5248
Funding
Agence Nationale de la Recherche (ANR) ANR-11-INBS-0006Agence Nationale de la Recherche (ANR) NAN-4-TUMEU H2020 814607EU Horizon Europe 101136835Ligue Contre le Cancer (French League Against Cancer) EL2016 EL2021 LNCCLiPLigue Contre le Cancer (French League Against Cancer) PhD fellowship
Abstract
Fluorine magnetic resonance imaging (
Indexed as
DendrimersFluorineTheranostic NanomedicineAnimalsCell Line, TumorContrast MediaFluorine-19 Magnetic Resonance ImagingHumansMagnetic Resonance ImagingMiceMice, NudePaclitaxelPancreatic NeoplasmsContrast MediaDendrimersFluorinePaclitaxeldendrimerMRImultimodal imagingself-assemblytheranostics
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.